Taken together, the decreased percentage of naive T cells associated with higher percentages of TEM expressing both activation markers and ICP molecules and of terminally differentiated TIGIT+ CD8+ TEMRA (Figs 2 and 3) reflects a strong activation of T cells during tumor development in FL patients before any treatment. The gene discussed is TIGIT; the disease is neoplasm.